The ICU staple has recently spiked in price. There's a cheaper, compounded alternative — but its at the center of a thicket of lawsuits and regulations.
Join our March conference call: Digging into Amarin’s REDUCE-IT data
Join STAT senior writers Matt Herper and Adam Feuerstein, and Dr. Michael Davidson, Professor of Medicine and Director of the Lipid Clinic at the University of Chicago for our first STAT Expert Advantage conference call: Digging into Amarin’s REDUCE-IT data. They’ll discuss the new Vascepa data being presented at the meeting of the American College of Cardiology, its potential impact for patients, and the outlook for Amarin’s business. Become a member of STAT Expert Advantage today to access this fully compliant call — and others like it throughout the year.
